Overall KYTX gets a fundamental rating of 1 out of 10. We evaluated KYTX against 525 industry peers in the Biotechnology industry. While KYTX seems to be doing ok healthwise, there are quite some concerns on its profitability. KYTX has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year KYTX has reported negative net income.
KYTX had a negative operating cash flow in the past year.

1.2 Ratios

KYTX's Return On Assets of -86.02% is on the low side compared to the rest of the industry. KYTX is outperformed by 71.05% of its industry peers.
Looking at the Return On Equity, with a value of -105.95%, KYTX is in line with its industry, outperforming 44.19% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-86.02%
ROE	-105.95%
ROIC	N/A

ROA(3y)-55.05%

ROA(5y)N/A

ROE(3y)-77.43%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KYTX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, KYTX has more shares outstanding
Compared to 1 year ago, KYTX has an improved debt to assets ratio.

2.2 Solvency

KYTX has an Altman-Z score of 2.27. This is not the best score and indicates that KYTX is in the grey zone with still only limited risk for bankruptcy at the moment.
KYTX's Altman-Z score of 2.27 is fine compared to the rest of the industry. KYTX outperforms 67.05% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KYTX is not too dependend on debt financing.
KYTX has a Debt to Equity ratio (0.00) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.27

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 5.16 indicates that KYTX has no problem at all paying its short term obligations.
The Current ratio of KYTX (5.16) is comparable to the rest of the industry.
A Quick Ratio of 5.16 indicates that KYTX has no problem at all paying its short term obligations.
KYTX has a Quick ratio (5.16) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	5.16
Quick Ratio	5.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.33% over the past year.

EPS 1Y (TTM)87.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-6.25%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -4.26% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-8.91%

EPS Next 2Y-1.26%

EPS Next 3Y1.66%

EPS Next 5Y-4.26%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

KYTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KYTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.